Earnings

West Pharmaceutical Servs Q3 Adj. EPS $2.66 Beats $2.19 Estimate, Sales $874.500M Beat $825.700M Estimate

Oct 29, 2026 · 06:03 AM ET· updated 1h ago

West Pharmaceutical Servs (NYSE:WST) reported quarterly earnings of $2.66 per share which beat the analyst consensus estimate of $2.19 by 21.46 percent. This is a 35.71 percent increase over earnings of $1.96 per share

Why It Matters

West Pharmaceutical made more money than people expected this quarter. When a company beats its targets, it might mean the business is running really well.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.

Tickers in Play

WST420.00

+16.36 (+4.05%)

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.